Dr. Sachin Almel
Educational Qualification:
07.07.1997 – 07.09.1997
13.07.1995 – 19.01.1997
01.05.1995 – 12.07.1995
30.01.1993 – 30.04.1995
01.09.1989 – 28.01.1993
He has also been involved in various clinical trials conducted at the Institute, the most notable being the MCP-841 and MCP-842 trials in collaboration with National Cancer Institute, U.S.A. for Acute Leukemia and High Grade Non-Hodgkin's lymphomas. During his basic training in department of Internal Medicine, he has worked in-
Clinical Trials Experience:
No. of years of experience in clinical trials: 5 Years
Project Title: A Randomized, Double-Blind, and Multicentere Study of xxx Compared with Zoledronic Acid (Zometa) in the Treatment of Bone Metastases in subjects with Prostrate Cancer
PI: DR ASHA KAPADIA
CO-PI: DR SACHIN V ALMEL
Project Title: A Randomized phase 2 Trial of Double-Blind, Placebo Controlled xxx in Combination with Paclitaxel, as First Line Therapy in Women with HER2Negative Locally Recurrent or Metastatic Breast Cancer
PI: DR SACHIN ALMEL
CO-PI:DR ASHA KAPADIA
Project Title: A Randomised, Double-Blind, Placebo-Controlled, Multicentre, Phase III Study of Post - Operative Adjuvant XXX or Placebo and Concurrent Chemoradiotherapy Followed by Maintenance XXX or Placebo Monotherapy in High-Risk Subjects with Resected Squamous Cell Carcinoma of Head and Neck (SCCHN).”
PI: DR SACHIN ALMEL
CO-PI: DR ASHA KAPADIA
Project Title: A multicentere, open-label, phase II study of XXX XXX for efficacy and Safety in patients with Metastatic breast cancer
PI: DR SACHIN ALMEL
CO-PI: DR ASHA KAPADIA
Project Title: A Randomized, Open-Label, Multicenter, Phase 3 Study of xxx Plus Standard Supportive Care versus Standard Supportive Care in Anemic Patients with Metastatic Breast Cancer Receiving Standard Chemotherapy
PI: DR SACHIN ALMEL
CO-PI: DR ASHA KAPADIA
Project Title: A Phase 1b / 2 Trial of XXX or XXX in Combination with Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer”
PI: DR SACHIN ALMEL
CO-PI: DR ASHA KAPADIA
Project Title: A Phase 3, Randomized, Double-Blinded Study of xxxxxxxxxx and Best Supportive Care (BSC) Versus Placebo and BSC in the Treatment of Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Following Disease Progression on First-Line Platinum- or Fluoropyrimidine-Containing Combination Therapy
PI: DR SACHIN ALMEL
CO-PI: DR ASHA KAPADIA
Project Title: A Phase 3, randomized, double-blind, placebo-controlled study of oral xxx in addition to best supportive care in patients with non-small cell lung cancer who have failed two or more prior treatment regimens
PI: DR SACHIN ALMEL
CO-PI: DR ASHA KAPADIA
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of xxxxxxxx as Adjuvant Treatment for Women with Early-Stage Breast Cancer at High Risk of Recurrence (D-CARE).
PI: DR SACHIN ALMEL
CO-PI: DR ASHA KAPADIA
ICH-GCP Training:
Has Received ICH-GCP Training at PI meet held at Bangkok on 26th and 27th July 2008